StockData

Yubo International Biotech Ltd (YBGJ) income statement

YBGJOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$0.01+0.00 (0.00%)

Close on Oct 16, 2026Market cap $886.19KP/E –Yield –

Yubo International Biotech Ltd income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
66.1%
Operating margin
-9096.9%
Net margin
-8157.3%
Return on equity, FY2026
40.1%

Financial strength

Current ratio
0.18
Debt to equity
–
Debt to assets
–
Cash to current liabilities
0.4%

Valuation

P/E ratio
–
Price to sales
71.74
Price to book
–
Dividend yield
–

See a number that looks wrong?